Journal
CANCERS
Volume 13, Issue 1, Pages -Publisher
MDPI
DOI: 10.3390/cancers13010064
Keywords
evolutionary therapy; darwinian evolution; tumor microenvironment; cancer cells subpopulations; diclofenac; koningic acid; spheroid; 3D co-culture
Categories
Funding
- NCI [R01CA077571]
- NIH/NCI PSOC [1U54CA193489]
Ask authors/readers for more resources
Utilizing selective biological forces to manipulate intracellular and extracellular pH levels can control tumor progression and guide it towards a less invasive trajectory. This approach can lead to the inhibition of aggressive cancer cell populations in favor of slower growth and less damage to patients, ultimately controlling cancer in cases where a cure is not an option.
Evolutionary dynamics can be used to control cancers when a cure is not clinically considered to be achievable. Understanding Darwinian intratumoral interactions of microenvironmental selection forces can be used to steer tumor progression towards a less invasive trajectory. Here, we approach intratumoral heterogeneity and evolution as a dynamic interaction among subpopulations through the application of small, but selective biological forces such as intracellular pH (pHi) and/or extracellular pH (pHe) vulnerabilities. Increased glycolysis is a prominent phenotype of cancer cells under hypoxia or normoxia (Warburg effect). Glycolysis leads to an important aspect of cancer metabolism: reduced pHe and higher pHi. We recently showed that decreasing pHi and targeting pHi sensitive enzymes can reverse the Warburg effect (WE) phenotype and inhibit tumor progression. Herein, we used diclofenac (DIC) repurposed to control MCT activity, and Koningic acid (KA) that is a GAPDH partial inhibitor, and observed that we can control the subpopulation of cancer cells with WE phenotype within a tumor in favor of a less aggressive phenotype without a WE to control progression and metastasis. In a 3D spheroid co-cultures, we showed that our strategy can control the growth of more aggressive MDA-MB-231 cells, while sparing the less aggressive MCF7 cells. In an animal model, we show that our approach can reduce tumor growth and metastasis. We thus propose that evolutionary dynamics can be used to control tumor cells' clonal or sub-clonal populations in favor of slower growth and less damage to patients. We propose that this can result in cancer control for tumors where cure is not an option.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available